Patients With Stomach Cancer May Not Be Benefiting From A Major Study Showing Chemotherapy And Radiation Prolong Life After Surgery

New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.

“We were surprised to learn that there are still many patients who are not receiving the gold standard of chemotherapy and radiation after surgery – despite compelling clinical data available since 2001. However, it is encouraging to see there has been a significant increase in the use of chemo-radiotherapy since it became the standard of care,” said Kristian Enestvedt, M.D., principal investigator, Department of Surgery, OHSU School of Medicine, OHSU Cancer Institute.

Patients With Stomach Cancer May Not Be Benefiting From A Major Study Showing Chemotherapy And Radiation Prolong Life After Surgery

New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.

“We were surprised to learn that there are still many patients who are not receiving the gold standard of chemotherapy and radiation after surgery – despite compelling clinical data available since 2001. However, it is encouraging to see there has been a significant increase in the use of chemo-radiotherapy since it became the standard of care,” said Kristian Enestvedt, M.D., principal investigator, Department of Surgery, OHSU School of Medicine, OHSU Cancer Institute.